Tradeoffs

@tradeoffspod

Podcast exploring our confusing, costly, often counterintuitive health care system. Hosted by . New episode every other Wed

Vrijeme pridruživanja: veljača 2019.

Tweetovi

Blokirali ste korisnika/cu @tradeoffspod

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @tradeoffspod

  1. Prikvačeni tweet
    22. sij

    💊💰NEW EP💊💰 Every time the U.S. tries to rein in rising drug prices, we hear the same thing from pharma: Stymie our profits, and you’ll get less innovation and fewer breakthrough treatments. Does the evidence back up this constant refrain? LISTEN:

    Poništi
  2. prije 16 minuta

    🗳️⚕️NEW EP🗳️⚕️ Iowa was ... a mess. But at least one thing was clear: Democratic voters are thinking a lot about health care. We look at the polls and talk with voters to break down how and why health care is shaping the 2020 election so far. LISTEN:

    Poništi
  3. prije 22 sata

    No Iowa results? No problem. We're diving deep this week with 's and producer on how and why health care is shaping the 2020 election so far. Subscribe:

    Poništi
  4. 3. velj

    Participating in the tonight but still making up your mind on versus a ? Our first episode is a pretty good primer comparing the two plans.

    Poništi
  5. 3. velj

    A remains more popular than in the latest tracking poll. But support for both is growing. We're talking polls, voters and health care this week with 's . Subscribe:

    Poništi
  6. proslijedio/la je Tweet
    31. sij

    Having flashbacks to episode 5 on value-based insurance design. If you're not familiar with the subject, it's a great overview: cc

    Poništi
  7. 29. sij

    We'll be diving into the polls and talking to voters about why health care is so important to them on next week's episode.

    Poništi
  8. 28. sij

    ICYMI: We explore the evidence on one of the crucial questions in the debate over prescription drug pricing... What will happen to innovation if we lower drug prices? LISTEN:

    Poništi
  9. 27. sij

    Be sure to check out today's episode of from to hear our own talk with about why he started Tradeoffs, how we decide which stories to tell and more.

    Poništi
  10. proslijedio/la je Tweet
    24. sij

    Tradeoff's talked to about this episode, what he learned about the process of getting a potential drug to market and much more. Tune into Monday to hear our conversation.

    Poništi
  11. 24. sij

    The U.S. spends a lot of money on prescription drugs. We also develop and bring to market a lot of breakthrough treatments. Can we rein in one without risking the other?

    Poništi
  12. proslijedio/la je Tweet
    23. sij

    So far, the "hotspotting" model of nurturing the sickest and most expensive patients has had disappointing results. But hospitals, insurers and govt health programs don’t intend to give up on the idea, report.

    Prikaži ovu nit
    Poništi
  13. 23. sij

    "So many podcasts, so little time—and only two ears to listen with. But Dan Gorenstein’s new Tradeoffs podcast belongs in your queue."

    Poništi
  14. 23. sij

    Republicans and Democrats say they want to lower prescription drug prices. Drugmakers say doing so would make it harder to develop life-changing treatments. What does the evidence say?

    Poništi
  15. proslijedio/la je Tweet
    23. sij

    If you’re not already listening to - here’s one to start with!

    Poništi
  16. 22. sij

    We love seeing Tradeoffs being used in the classroom!

    Poništi
  17. proslijedio/la je Tweet

    We’ve all heard drugmakers claim lowering drug prices will cut innovative new therapies. looks at the evidence: does reducing profits hurt innovation? Or can we lower prices and keep getting the game-changing drugs everyone wants?

    Poništi
  18. proslijedio/la je Tweet
    Poništi
  19. 21. sij

    Tomorrow, we use the evidence to put pharma's drug pricing argument to the test: Would lowering drug prices lead to less innovation? Subscribe today:

    Poništi
  20. proslijedio/la je Tweet
    19. sij

    "Early signs indicate is reaching influencers, including prominent journalists, health care executives, and leading researchers." CHCF and are proud to support this new podcast!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·